Good morning Ron, saw your first post at 7:00 AM

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

s402005

Rank: Treasurer [?]

Points: 5795 [?]

Votes: 78 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Good morning Ron, saw your first post at 7:00 AM

posted on Aug 10, 2007 05:01AM

I thougth about it a couple of weeks ago and now it seems to me that more and more questions and discussuions are going in the direction of the 336 and 148 patents as the 584 maybe will be excluded from the TX case.

What could happen if the 336 and the 148 are also objected by the USPTO soon with our TX case after a ruling in January. Are the J3 than able to appeal the rulling in total (that's always possible, I know) or furthermore they go to trial based on a USPTO decison again?

I rememebr from old postings, that we have to separate the reex. from TX. However, we've learnt from the 584 that we shouldn't underastimate the influence from both institutions on the particuar work and decisons.